Acrivon Therapeutics, Inc. (ACRV)
(Delayed Data from NSDQ)
$9.36 USD
+0.67 (7.71%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $9.25 -0.11 (-1.18%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Earnings News For ACRV
-
Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights